• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Kessler Foundation study compares neuropsychological tests for assessing deficits in MS

Bioengineer by Bioengineer
May 24, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Kessler Foundation

East Hanover, NJ. May 24, 2018. A recent article by Kessler Foundation researchers compared two neuropsychological tests for assessing learning in individuals with multiple sclerosis (MS). The article, "Comparing the Open Trial – Selective Reminding Test results with the California Learning Verbal Test II in Multiple Sclerosis" was published online on April 4, 2018, in Applied Neuropsychology: Adult.

This is the first study to compare the two tests in the same individuals with MS. The authors are Silvana L. Costa, PhD, John DeLuca, PhD, Kristen Costanza and Nancy Chiaravalloti, PhD of Kessler Foundation. The article link is: https://doi.org/10.1080/23279095.2018.1448818

Researchers administered the tests to 112 individuals with MS, 79 women and 33 men. Results showed clear differences in performance on the California Verbal Learning Test (CVLT-II) and the Open Trial Selective Reminding Test (OT-SRT). On the OT-SRT, all participants were identified as impaired, while only 34 percent were similarly identified on the CLV-TII. Differences in administration of the tests may explain this disparity. With the OT-SRT learning and memory are tested with minimal reliance on other cognitive abilities. With the CVLTII, reliance on other cognitive abilities is more prominent, likely affecting the testing results.

"It is essential that the neuropsychological assessment accurately pinpoint the deficits in MS," said Dr. Costa, the lead author. "This is fundamental to developing interventions to address these deficits, and tailoring cognitive rehabilitation programs for maximal outcomes in this population."

###

This research was supported by National Institutes of Health 1R01HD045798, International Progressive MS Alliance grant PA0128, National MS Society grants PP1952 and MB 0024, National Institute for Disability, Independent Living Rehabilitation Research grant 90SF0012-01-00, and the Hearst Foundation.

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.

For more information, or to interview an expert, contact: Carolann Murphy, 973.324.8382, [email protected].

Media Contact

Carolann Murphy
[email protected]
973-324-8382
@KesslerFdn

http://www.KesslerFoundation.org

Related Journal Article

http://dx.doi.org/10.1080/23279095.2018.1448818

Share12Tweet8Share2ShareShareShare2

Related Posts

Teamwork Triumphs: Patient Safety in COVID-19 Care

October 27, 2025

Unlocking Henna’s Healing Power: A Breakthrough Chemical from Lawsonia inermis Fights Fibrosis

October 27, 2025

ACHO: Enhancing Treatment Adherence through Digital Care

October 27, 2025

Decline in Opioid Prescriptions for Pain Management Observed in Canada

October 27, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1285 shares
    Share 513 Tweet 321
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    310 shares
    Share 124 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    197 shares
    Share 79 Tweet 49
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    134 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Teamwork Triumphs: Patient Safety in COVID-19 Care

ABCD2 Enhances Carotid Stenosis Diagnosis with CT Angiography

Dipeptide’s Impact on Ionic Liquid Micellization Explored

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.